Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00307086
Status:
COMPLETED
Last Update Posted:
2017-03-06
First Post:
2006-03-23
Brief Title:
Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Plasma Cell Leukemia |
| Multiple Myeloma |
Keywords: